IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity-Reference-Cited by-同舟云学术

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity

Published:2011-09 Issue:15-16 Volume:48 Page:2087-2093
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Hansen Mikkel L.,Woetmann Anders,Krejsgaard Thorbjørn,Kopp Katharina L.M.,Søkilde Rolf,Litman Thomas,Straten Per T.,Geisler Carsten,Wasik Mariusz A.,Ødum Niels,Eriksen Karsten W.

Funder

University of Copenhagen

Danish Research Councils

Copenhagen Cluster of Immunology

Novo Nordic Foundation

Lundbeck Foundation

Danish National Advanced Technology Foundation (Højteknologifonden)

Neye foundation

Danish Medical Association Research Foundation

Danish Cancer Research Foundation

Danish Cancer Society

Carlsberg foundation, Alfred Benzon Foundation

Gerda and Aage Haenschs Foundation

Augustinus foundation

A.P. Møller Foundation for the Advancement of Medical Science

Fabrikant Vilhelm Pedersen og hustrus Mindelegat, Direktør Jacob Madsen & hustrus Fond

U.S. National Cancer Institute

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference30 articles.

1. Interferon-alpha as an immunotherapeutic protein;Brassard;J. Leukoc. Biol.,2002

2. Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells;Brender;Exp. Clin. Immunogenet.,2001

3. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis;Burkett;J. Exp. Med.,2004

4. Signalling, inflammation and arthritis: crossed signals: the role of interleukin-15 and -18 in autoimmunity;Carroll;Rheumatology (Oxford),2008

5. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression;Dickensheets;Proc. Natl. Acad. Sci. U. S. A.,1999

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers;Cancer Drug Resistance;2024-05-13

2. CAR-NK cells for cancer immunotherapy: recent advances and future directions;Frontiers in Immunology;2024-02-09

3. Exploiting innate immunity for cancer immunotherapy;Molecular Cancer;2023-11-27

4. Virtual Memory CD8⁺ T Cells: Origin and Beyond;Journal of Interferon & Cytokine Research;2022-12-01

5. Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells;Frontiers in Immunology;2022-11-24